# Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

> clinical trial · VERIFIED · 2026-06-30

Status: NOT_YET_RECRUITING · Sponsor: The Affiliated People's Hospital of Ningbo University · Condition: Acute Promyelocytic Leukemia (APL)

- Company: The Affiliated People's Hospital of Ningbo University
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07597941

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.